SGLT2 inhibitors and angiotensin receptor neprilysin inhibitors (ARNis) are the ‘new kids on the block’ in the latest update of national heart failure guidelines presented at CSANZ 2018. The National Heart Foundation of Australia and CSANZ Guidelines for the Prevention, Detection and Management of Heart Failure in Australia 2018 are a significant revision of the 2011 ...
What’s new in the updated CSANZ Heart Failure guidelines
By Mardi Chapman
13 Aug 2018